Teva Pharmaceuticals
TEVA
TEVA
875 hedge funds and large institutions have $40B invested in Teva Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 134 funds opening new positions, 290 increasing their positions, 310 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 823 → 875 (+52)
4.84% more ownership
Funds ownership: 55.28% → 60.12% (+4.8%)
6% less repeat investments, than reductions
Existing positions increased: 290 | Existing positions reduced: 310
Holders
875
Holding in Top 10
87
Calls
$1.18B
Puts
$662M
Top Buyers
| 1 | +$1.06B | |
| 2 | +$819M | |
| 3 | +$504M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$395M |
| 5 |
IC
Institutional Capital
Chicago,
Illinois
|
+$286M |
Top Sellers
| 1 | -$457M | |
| 2 | -$259M | |
| 3 | -$154M | |
| 4 |
NTC
North Tide Capital
Boston,
Massachusetts
|
-$112M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$106M |